STOCK TITAN

Recursion (NASDAQ: RXRX) director sells 40,000 shares under 10b5-1 plan

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Recursion Pharmaceuticals director Christopher Gibson reported an insider trade involving the company’s Class A and Class B shares. On June 5, 2026, he converted 40,000 shares of Class B Common Stock into 40,000 shares of Class A Common Stock and sold those Class A shares at $3.62 per share.

The filing states this sale was made pursuant to a Rule 10b5-1 trading plan adopted on May 12, 2025, indicating it was pre-planned. After these transactions, Gibson held 923,735 shares of Class A Common Stock and 4,263,334 shares of Class B Common Stock directly, suggesting the 40,000-share sale represents only a small portion of his overall position.

Positive

  • None.

Negative

  • None.
Insider Gibson Christopher
Role null
Sold 40,000 shs ($145K)
Type Security Shares Price Value
Conversion Class B Common Stock 40,000 $0.00 --
Conversion Class A Common Stock 40,000 $0.00 --
Sale Class A Common Stock 40,000 $3.62 $145K
holding Class B Common Stock -- -- --
holding Class B Common Stock -- -- --
holding Class B Common Stock -- -- --
holding Stock Option (Right to Buy) -- -- --
holding Stock Option (Right to Buy) -- -- --
holding Stock Option (Right to Buy) -- -- --
holding Stock Option (Right to Buy) -- -- --
holding Stock Option (Right to Buy) -- -- --
holding Stock Option (Right to Buy) -- -- --
Holdings After Transaction: Class B Common Stock — 4,263,334 shares (Direct, null); Class A Common Stock — 923,735 shares (Direct, null); Class B Common Stock — 0 shares (Indirect, by LAHWRAN-3 LLC); Stock Option (Right to Buy) — 0 shares (Direct, null)
Footnotes (1)
  1. Represents the automatic conversion of Class B Common Stock into Class A Common Stock in connection with a sale of the shares by the Reporting Person. Each share of Class B Common Stock is convertible into one share of Class A Common Stock. This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2025. Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. The shares are held by LAHWRAN-3 LLC, of which the Reporting Person is a member and a manager. The shares are held by LAHWRAN-4 LLC, of which the Reporting Person is a member and a manager. The shares are held by the Gibson Family Trust, of which the Reporting Person serves as Trustee. The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2025, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter. The option vests as to one forty-eighth (1/48th) of the original 666,898 shares subject to the option on March 1, 2024, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter. The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2023, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter. The option, originally for 416,350 shares, vested as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2022, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter. The option, originally for 1,500,000 shares, vested as to one forty-eighth (1/48th) of the shares subject to the option on January 31, 2021, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter.
Shares sold 40,000 shares Class A Common Stock sold on June 5, 2026
Sale price $3.62 per share Price for 40,000 Class A shares sold
Class A holdings after 923,735 shares Direct Class A Common Stock after transactions
Class B holdings after 4,263,334 shares Direct Class B Common Stock after derivative conversion
Converted shares 40,000 shares Class B converted into Class A on June 5, 2026
Rule 10b5-1 plan adoption May 12, 2025 Plan governing the June 5, 2026 sale
Rule 10b5-1 trading plan regulatory
"This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2025."
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
Class B Common Stock financial
"Represents the automatic conversion of Class B Common Stock into Class A Common Stock in connection with a sale of the shares."
A class B common stock is one of multiple types of a company’s ordinary shares that carries specific rights—often different voting power or dividend priority—compared with other classes. For investors it matters because those differences affect how much influence you have over company decisions, the income you might receive, and how freely the shares trade; think of it like owning a car with different keys: some keys let you start the engine and open the trunk, others only unlock the door.
derivative conversion financial
"Transaction code C is described as a derivative conversion of Class B Common Stock into Class A Common Stock."
Stock Option (Right to Buy financial
"Several holdings are listed as Stock Option (Right to Buy) with various exercise prices and expirations."
open-market sale financial
"Transaction code S is described as a sale in open market or private transaction for Class A Common Stock."
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Gibson Christopher

(Last)(First)(Middle)
C/O RECURSION PHARMACEUTICALS
41 S. RIO GRANDE STREET

(Street)
SALT LAKE CITY UTAH 84101

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
RECURSION PHARMACEUTICALS, INC. [ RXRX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/05/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Class A Common Stock06/05/2026C(1)(2)40,000A$0923,735D
Class A Common Stock06/05/2026S(2)40,000D$3.62883,735D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Class B Common Stock$0(3)06/05/2026C(1)(2)40,000 (3) (3)Class A Common Stock40,000$04,263,334D
Class B Common Stock$0 (3) (3)Class A Common Stock0386,000Iby LAHWRAN-3 LLC(4)
Class B Common Stock$0 (3) (3)Class A Common Stock0388,000Iby LAHWRAN-4 LLC(5)
Class B Common Stock$0 (3) (3)Class A Common Stock050,000Iby Gibson Family Trust(6)
Stock Option (Right to Buy)$7.25 (7)02/03/2035Class A Common Stock01,050,567D
Stock Option (Right to Buy)$10.09 (8)02/09/2034Class A Common Stock0666,898D
Stock Option (Right to Buy)$8.55 (9)02/01/2033Class A Common Stock0813,600D
Stock Option (Right to Buy)$11.4 (10)02/04/2032Class A Common Stock0399,002D
Stock Option (Right to Buy)$11.402/04/202202/04/2032Class A Common Stock05,436D
Stock Option (Right to Buy)$2.48 (11)12/30/2030Class A Common Stock0282,500D
Explanation of Responses:
1. Represents the automatic conversion of Class B Common Stock into Class A Common Stock in connection with a sale of the shares by the Reporting Person. Each share of Class B Common Stock is convertible into one share of Class A Common Stock.
2. This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2025.
3. Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date.
4. The shares are held by LAHWRAN-3 LLC, of which the Reporting Person is a member and a manager.
5. The shares are held by LAHWRAN-4 LLC, of which the Reporting Person is a member and a manager.
6. The shares are held by the Gibson Family Trust, of which the Reporting Person serves as Trustee.
7. The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2025, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter.
8. The option vests as to one forty-eighth (1/48th) of the original 666,898 shares subject to the option on March 1, 2024, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter.
9. The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2023, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter.
10. The option, originally for 416,350 shares, vested as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2022, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter.
11. The option, originally for 1,500,000 shares, vested as to one forty-eighth (1/48th) of the shares subject to the option on January 31, 2021, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter.
Remarks:
/s/Jonathan Golightly, attorney-in-fact06/05/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Christopher Gibson report for RXRX?

Christopher Gibson reported converting 40,000 Class B shares into 40,000 Class A shares and selling those Class A shares at $3.62 each. The trade was disclosed as an open-market or private sale on June 5, 2026, in a Form 4 filing.

How many Recursion (RXRX) shares did Christopher Gibson sell?

Christopher Gibson sold 40,000 shares of Recursion Class A Common Stock. These shares came from a same-day conversion of 40,000 Class B shares into Class A shares, as described in the Form 4 and related footnotes.

At what price were Christopher Gibson’s RXRX shares sold?

The 40,000 Class A shares were sold at $3.62 per share. This price reflects the per-share value at which the open-market or private transaction was executed on June 5, 2026, according to the Form 4 disclosure.

Was Christopher Gibson’s RXRX share sale under a 10b5-1 plan?

Yes. A footnote explains the transaction occurred under a Rule 10b5-1 trading plan adopted on May 12, 2025. Such plans pre-schedule trades, indicating the timing of this 40,000-share sale was arranged in advance rather than decided opportunistically.

How many RXRX Class A shares does Christopher Gibson hold after the trade?

After the reported transactions, Christopher Gibson directly holds 923,735 shares of Class A Common Stock. This post-transaction balance shows he retained a substantial position in Recursion shares despite selling 40,000 Class A shares on June 5, 2026.

What is Christopher Gibson’s Class B Common Stock position at RXRX?

Following the derivative conversion, Christopher Gibson directly holds 4,263,334 shares of Class B Common Stock. A footnote states each Class B share is convertible into one Class A share and has no expiration date, providing long-term flexibility.